Abstract
An adequate quantity and quality of sleep are important to maintain health. Insomnia is common and can result in significant distress and impaired daytime functioning. This article seeks to raise nurses' awareness of the evidence surrounding insomnia and the guidance relating to its management. It focuses particularly on the role of the hormone melatonin and recent developments in the use of synthesised melatonin as a treatment for primary insomnia in people aged over 55.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
